Overview

Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

The objective of this NIS is to assess in a real-life setting, usage patterns and associated outcomes in the management (healthcare resource utilisation and associated costs) of patients with acute deep vein thrombosis treated with Xarelto, in accordance with the terms of the European marketing authorization and the Belgian reimbursement criteria.

Details

Lead Sponsor:

Bayer

Collaborator:

Janssen Scientific Affairs, LLC

Treatments:

Rivaroxaban